Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Ambee Pharmaceuticals Statistics

Total Valuation

DSE:AMBEEPHA has a market cap or net worth of BDT 1.76 billion. The enterprise value is 2.31 billion.

Market Cap	1.76B
Enterprise Value	2.31B

Important Dates

The next estimated earnings date is Wednesday, January 21, 2026.

Earnings Date	Jan 21, 2026
Ex-Dividend Date	Nov 23, 2025

Share Statistics

DSE:AMBEEPHA has 2.40 million shares outstanding.

Current Share Class	2.40M
Shares Outstanding	2.40M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	77.25%
Owned by Institutions (%)	n/a
Float	545,941

Valuation Ratios

The trailing PE ratio is 364.10.

PE Ratio	364.10
Forward PE	n/a
PS Ratio	9.05
PB Ratio	52.34
P/TBV Ratio	52.34
P/FCF Ratio	n/a
P/OCF Ratio	117.84
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	478.46
EV / Sales	11.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-259.14

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 20.36.

Current Ratio	0.84
Quick Ratio	0.47
Debt / Equity	20.36
Debt / EBITDA	94.47
Debt / FCF	-76.73
Interest Coverage	98.61

Financial Efficiency

Return on equity (ROE) is 14.91% and return on invested capital (ROIC) is 0.68%.

Return on Equity (ROE)	14.91%
Return on Assets (ROA)	0.62%
Return on Invested Capital (ROIC)	0.68%
Return on Capital Employed (ROCE)	18.16%
Revenue Per Employee	409,063
Profits Per Employee	10,170
Employee Count	474
Asset Turnover	0.28
Inventory Turnover	0.45

Taxes

In the past 12 months, DSE:AMBEEPHA has paid 1.89 million in taxes.

Income Tax	1.89M
Effective Tax Rate	28.21%

Stock Price Statistics

The stock price has increased by +2.05% in the last 52 weeks. The beta is -0.39, so DSE:AMBEEPHA's price volatility has been lower than the market average.

Beta (5Y)	-0.39
52-Week Price Change	+2.05%
50-Day Moving Average	786.48
200-Day Moving Average	790.65
Relative Strength Index (RSI)	32.24
Average Volume (20 Days)	1,205

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:AMBEEPHA had revenue of BDT 193.90 million and earned 4.82 million in profits. Earnings per share was 2.01.

Revenue	193.90M
Gross Profit	91.72M
Operating Income	6.78M
Pretax Income	6.71M
Net Income	4.82M
EBITDA	n/a
EBIT	6.78M
Earnings Per Share (EPS)	2.01

Balance Sheet

The company has 131.65 million in cash and 682.89 million in debt, giving a net cash position of -551.24 million or -229.68 per share.

Cash & Cash Equivalents	131.65M
Total Debt	682.89M
Net Cash	-551.24M
Net Cash Per Share	-229.68
Equity (Book Value)	33.53M
Book Value Per Share	13.97
Working Capital	-116.31M

Cash Flow

In the last 12 months, operating cash flow was 14.89 million and capital expenditures -23.79 million, giving a free cash flow of -8.90 million.

Operating Cash Flow	14.89M
Capital Expenditures	-23.79M
Free Cash Flow	-8.90M
FCF Per Share	-3.71

Margins

Gross margin is 47.31%, with operating and profit margins of 3.50% and 2.49%.

Gross Margin	47.31%
Operating Margin	3.50%
Pretax Margin	3.46%
Profit Margin	2.49%
EBITDA Margin	n/a
EBIT Margin	3.50%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.14%.

Dividend Per Share	1.00
Dividend Yield	0.14%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	49.77%
Buyback Yield	n/a
Shareholder Yield	0.14%
Earnings Yield	0.27%
FCF Yield	-0.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 29, 2014. It was a forward split with a ratio of 1.2.

Last Split Date	May 29, 2014
Split Type	Forward
Split Ratio	1.2

Scores

DSE:AMBEEPHA has an Altman Z-Score of 1.67 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.67
Piotroski F-Score	4